SR&ED for Medical Device Companies in Canada

Canadian medical device and medtech companies regularly qualify for SR&ED credits on prototype development, clinical validation, regulatory testing, and manufacturing process innovation — if the work involved genuine technical uncertainty.

What medical device R&D qualifies for SR&ED?

Medical device SR&ED eligibility follows the same three-part CRA test as any other industry: technological uncertainty, systematic investigation, and technological advancement. What differs is how these apply in practice. Device companies often have strong eligibility across multiple work streams — hardware, embedded firmware, manufacturing, and clinical validation can all qualify independently.

• Novel device architecture where biocompatibility, performance, or durability were uncertain
• Embedded firmware and control systems for devices with no commercial precedent
• Human factors engineering studies requiring iterative design and testing cycles
• Sensor integration, signal processing, and data interpretation algorithms
• Miniaturization or novel material development with uncertain performance outcomes
• Custom manufacturing process development for device-specific tolerances

Prototype development and iterative bench testing

Prototype development is SR&ED when the work reveals and resolves technical uncertainty through experimentation. The hallmark of qualifying work is a documented cycle: hypothesize, build, test, analyze failure, revise. Design history files maintained throughout this process are excellent SR&ED evidence.

Routine engineering — adapting known designs using documented methods — does not qualify. But when a competent engineer could not have predicted whether a design would work without testing, that testing is SR&ED. Failure analysis, design revisions, and root-cause investigations are the records CRA looks for.

Clinical validation and usability studies

Clinical validation studies qualify for SR&ED when they investigate genuine technical uncertainty about whether the device performs as intended in clinical conditions. This includes first-in-human studies for novel device concepts, bench-to-bedside validation of novel measurement techniques, and clinical testing that reveals unexpected failure modes requiring design revision.

Usability engineering (per IEC 62366) can qualify when it reveals unexpected human factors issues that require engineering changes — not routine compliance testing of a finalized design. Document what changed after each usability session and why.

Health Canada regulatory submissions and testing

The portion of regulatory work that involves technological uncertainty qualifies for SR&ED. Developing a new test method, resolving an unexpected biocompatibility finding, or adapting a standard protocol to a novel material are examples of qualifying regulatory work. Running standard compliance tests against established protocols on a finalized device design generally does not qualify.

Manufacturing process innovation

Manufacturing SR&ED is often underutilized. When a medical device requires a manufacturing process that does not yet exist — novel bonding techniques, new clean-room protocols, sterile assembly methods for a new geometry — the development of that process is SR&ED. Biotech companies developing biologic manufacturing processes face similar eligibility.